Association of a pace of aging epigenetic clock with rate of cognitive decline in the Framingham Heart Study Offspring Cohort

Micah J. Savin,Harry Haoyang Wang,Heming Pei,Allison E. Aiello,Stephanie Assuras,Avshalom Caspi,Terrie E. Moffitt,Peter A. Muenning,Calen P. Ryan,Baoyi Shi,Yaakov Stern,Karen Sugden,Linda Valeri,Daniel W. Belsky
DOI: https://doi.org/10.1101/2024.05.21.24307683
2024-05-21
Abstract:Introduction: The geroscience hypothesis proposes systemic biological aging is a root cause of cognitive decline. Methods: We analyzed Framingham Heart Study Offspring Cohort data (n=2,296; 46% male; baseline age M=62, SD=9, range=25-101y). We measured cognitive decline across two decades of neuropsychological-testing follow-up. We measured pace of aging using the DunedinPACE epigenetic clock. Analysis tested if participants with faster DunedinPACE values experienced more rapid preclinical cognitive decline as compared to those with slower DunedinPACE values. Results: Participants with faster DunedinPACE had poorer cognitive functioning at baseline and experienced more rapid cognitive decline over follow-up. Results were robust to confounders and consistent across population strata. Findings were similar for the PhenoAge and GrimAge epigenetic clocks. Discussion: Faster pace of aging is a risk factor for preclinical cognitive decline. Metrics of biological aging may inform risk stratification in clinical trials and prognosis in patient care.
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the relationship between the rate of biological aging and the decline in cognitive function. In particular, it studies whether the rate of aging measured by the DunedinPACE epigenetic clock is related to the rate of cognitive decline in the Framingham Heart Study Offspring Cohort. Specifically, the paper aims to verify the hypothesis that some elderly people experience a faster decline in cognitive ability because their rate of biological aging is faster. In addition, the paper also explores whether this association is affected by other factors (such as smoking history, white blood cell composition in blood samples, mild cognitive impairment status at baseline, gender, and APOE4 carrier status), and evaluates whether accelerated cognitive decline mediates the relationship between the rate of biological aging and the risk of dementia.